{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:05:41Z","timestamp":1779318341619,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Der Begriff der diabetischen Neuropathie ist eine Sammelbezeichnung f\u00fcr Erkrankungen des peripheren Nervensystems, die als Sp\u00e4tkomplikation des Diabetes mellitus auftreten. Die Leitlinienempfehlungen beschreiben die klinischen Symptome und diagnostischen M\u00f6glichkeiten sowie die Therapiema\u00dfnahmen insbesondere bei der schmerzhaften Form der sensomotorischen Neuropathie einschlie\u00dflich der komplexen Problematik des diabetischen Fu\u00dfes.<\/jats:p>","DOI":"10.1007\/s00508-025-02675-8","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:12:56Z","timestamp":1779315176000},"page":"200-212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diabetische Neuropathie und diabetischer Fu\u00df (Update\u00a02026)","Diabetic neuropathy and diabetic foot syndrome (Update 2026)"],"prefix":"10.1007","volume":"138","author":[{"given":"Gerd","family":"K\u00f6hler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Feder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Hochfellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlies","family":"Eichner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"2675_CR1","volume-title":"Nationale Versorgungsleitlinie: Neuropathie bei Diabetes im Erwachsenenalter, Langversion","author":"-","year":"2011","unstructured":"-. Nationale Versorgungsleitlinie: Neuropathie bei Diabetes im Erwachsenenalter, Langversion. 1.\u00a0Aufl. 2011.","edition":"1"},{"key":"2675_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/b978-0-444-53480-4.00001-1","volume":"126","author":"D Ziegler","year":"2014","unstructured":"Ziegler\u00a0D, Papanas\u00a0N, Vinik\u00a0AI, Shaw\u00a0JE. Epidemiology of polyneuropathy in diabetes and prediabetes. Handb Clin Neurol. 2014;126:3\u201322. https:\/\/doi.org\/10.1016\/b978-0-444-53480-4.00001-1.","journal-title":"Handb Clin Neurol"},{"key":"2675_CR3","volume-title":"Update: Diabetische Neuropathie erfolgreich diagnostizieren und therapieren","author":"D Ziegler","year":"2024","unstructured":"Ziegler\u00a0D. Update: Diabetische Neuropathie erfolgreich diagnostizieren und therapieren. Rheinland-Pfalz: Akademie f\u00fcr \u00c4rztliche Fortbildung; 2024."},{"key":"2675_CR4","first-page":"1219","volume-title":"Peripheral Neuropathy","author":"PK Thomas","year":"1993","unstructured":"Thomas\u00a0PK, Tomlinson\u00a0DR. Diabetic and Hypoglycemic Neuropathy. In: Dyck\u00a0PJ, Thomas\u00a0PK, Hrsg. Peripheral Neuropathy. 3.\u00a0Aufl. Philadelphia: Saunders; 1993. S.\u00a01219\u201350.","edition":"3"},{"issue":"6","key":"2675_CR5","first-page":"521","volume":"11","author":"BC Callaghan","year":"2012","unstructured":"Callaghan\u00a0BC, Cheng\u00a0HT, Stables\u00a0CL, Smith\u00a0AL, Feldman\u00a0EL. Diabetic neuropathy: clinical manifestations and current treatments. LancetNeurol. 2012;11(6):521\u201334.","journal-title":"LancetNeurol"},{"issue":"1","key":"2675_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","volume":"5","author":"EL Feldman","year":"2019","unstructured":"Feldman\u00a0EL, Callaghan\u00a0BC, Pop-Busui\u00a0R, Zochodne\u00a0DW, Wright\u00a0DE, Bennett\u00a0DL, et\u00a0al. Diabetic neuropathy. Nat Rev Disprimers. 2019;5(1):41.","journal-title":"Nat Rev Disprimers"},{"issue":"3","key":"2675_CR7","first-page":"216","volume":"1","author":"D Ziegler","year":"2001","unstructured":"Ziegler\u00a0D. Diagnosis and treatment of diabetic autonomic neuropathy. CurrDiabRep. 2001;1(3):216\u201327.","journal-title":"CurrDiabRep"},{"issue":"2","key":"2675_CR8","doi-asserted-by":"publisher","first-page":"S339","DOI":"10.1055\/a-1916-2156","volume":"17","author":"M Kellerer","year":"2022","unstructured":"Kellerer\u00a0M, et\u00a0al. Praxisempfehlungen der Deutschen Diabetes Gesellschaft. Diabetologie. 2022;17(2):S339\u2013S53. https:\/\/doi.org\/10.1055\/a-1916-2156.","journal-title":"Diabetologie"},{"issue":"6","key":"2675_CR9","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1212\/WNL.42.6.1164","volume":"42","author":"PJ Dyck","year":"1992","unstructured":"Dyck\u00a0PJ, Karnes\u00a0JL, O\u2019Brien\u00a0PC, Litchy\u00a0WJ, Low\u00a0PA, Melton\u00a0LJ. The Rochester Diabetic Neuropathy Study: Reassessment of tests and criteria for diagnosis and staged severity. Neurology. 1992;42(6):1164\u201370.","journal-title":"Neurology"},{"issue":"4","key":"2675_CR10","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1212\/WNL.43.4.817","volume":"43","author":"PJ Dyck","year":"1993","unstructured":"Dyck\u00a0PJ, Kratz\u00a0KM, Karnes\u00a0JL, Litchy\u00a0WJ, Klein\u00a0R, Pach\u00a0JM, et\u00a0al. The prevalence by staged severity of various types of diabeticneuropathy, retinopathy, and nephropathy in a\u00a0population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43(4):817\u201324.","journal-title":"Neurology"},{"issue":"9","key":"2675_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1046\/j.1464-5491.2002.00778.x","volume":"19","author":"LV Van de Van de Poll-Franse","year":"2002","unstructured":"Van de Van de Poll-Franse\u00a0LV, Van de van Valk\u00a0GD, Renders\u00a0CM, Heine\u00a0RJ, van van Eijk\u00a0JTM. Longitudinal assessment of the development of diabeticpolyneuropathyandassociatedrisk factors. Diabet Med. 2002;19(9):771\u20136.","journal-title":"Diabet Med"},{"issue":"2","key":"2675_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/BF00400697","volume":"36","author":"MJ Young","year":"1993","unstructured":"Young\u00a0MJ, Boulton\u00a0AJ, MacLeod\u00a0AF, Williams\u00a0DR, Sonksen\u00a0PH. A\u00a0multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinicpopulation. Diabetologia. 1993;36(2):150\u20134.","journal-title":"Diabetologia"},{"issue":"11","key":"2675_CR13","first-page":"1456","volume":"38","author":"RE Maser","year":"1989","unstructured":"Maser\u00a0RE, Steenkiste\u00a0AR, Dorman\u00a0JS, Nielsen\u00a0VK, Bass\u00a0EB, Manjoo\u00a0Q, et\u00a0al. Epidemiological correlates of diabetic neuropathy. Rep From Pittsburgh Epidemiol Diabetes Complicat Studydiabetes. 1989;38(11):1456\u201361.","journal-title":"Rep From Pittsburgh Epidemiol Diabetes Complicat Studydiabetes"},{"issue":"1","key":"2675_CR14","first-page":"8","volume":"28","author":"S Tesfaye","year":"2012","unstructured":"Tesfaye\u00a0S, Selvarajah\u00a0D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. DiabetesMetabResRev. 2012;28(1):8\u201314.","journal-title":"DiabetesMetabResRev"},{"key":"2675_CR15","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s00125-017-4253-z","volume":"60","author":"The Look AHEAD Research Group","year":"2017","unstructured":"The Look AHEAD Research Group. Effects of a\u00a0long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type\u00a02 diabetes: the Look AHEAD study. Diabetologia. 2017;60:980\u20138.","journal-title":"Diabetologia"},{"key":"2675_CR16","doi-asserted-by":"publisher","unstructured":"Kandeel M, et\u00a0al. The outcomes of Sodium-Glucose Co-transporter 2\u00a0inhibitors (SGLT2I) on Diabetes-Associated Neuropathy: A\u00a0Systematic Review an meta-Analysis. 13:926717. https:\/\/doi.org\/10.3389\/fphar.2022.926717.","DOI":"10.3389\/fphar.2022.926717"},{"key":"2675_CR17","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00228.2024","author":"R Dhanapalaratnam","year":"2024","unstructured":"Dhanapalaratnam\u00a0R, et\u00a0al. Impact of glucagon-like peptide\u20111 receptor agonists on axonal function in diabetic peripheral neuropathy. JNP. 2024; https:\/\/doi.org\/10.1152\/jn.00228.2024.","journal-title":"JNP"},{"key":"2675_CR18","unstructured":"Gillhausen K, et\u00a0al. Diagnose und Therapie neuropathischer Schmerzen: eine praktische Hilfe f\u00fcr den haus\u00e4rztlichen Alltag https:\/\/docplayer.org\/123308213-Diagnose-undtherapie-neuropathischer-schmerzen.html. Zugegriffen: 30. Okt. 2022."},{"key":"2675_CR19","doi-asserted-by":"crossref","unstructured":"Schlereth T. Diagnose und nicht interventionelle Therapie neuropathischer Schmerzen, S2k-Leitlinie, 2019. Deutsche Gesellschaft f\u00fcr Neurologie https:\/\/dgn.org\/leitlinien. Zugegriffen: 30. Okt. 2022.","DOI":"10.1007\/s42451-019-00139-8"},{"key":"2675_CR20","volume-title":"Chronische periphere neuropathische Schmerzen: Diagnose und Therapie in der Praxis","author":"G Graggober","year":"2020","unstructured":"Graggober\u00a0G, et\u00a0al. Chronische periphere neuropathische Schmerzen: Diagnose und Therapie in der Praxis. SchmerzNachrichten; 2020."},{"key":"2675_CR21","doi-asserted-by":"publisher","first-page":"S322","DOI":"10.1055\/a-2312-0661","volume":"19","author":"D Ziegler","year":"2024","unstructured":"Ziegler\u00a0D, et\u00a0al. Diabetische Neuropathie. Diabetol Stoffwechs. 2024;19:S322\u2013S36. https:\/\/doi.org\/10.1055\/a-2312-0661.","journal-title":"Diabetol Stoffwechs"},{"key":"2675_CR22","unstructured":"Rittner H. Behandlung von Schmerzen bei peripherer diabetischer Polyneuropathie. Arzeiverordnung in der Praxis\/Band\u00a050\/Heft\u00a03 https:\/\/www.akdae.de\/arzneimitteltherapie\/arzneiverordnung-in-der-praxis\/ausgaben-archiv\/ausgaben-ab."},{"key":"2675_CR23","doi-asserted-by":"publisher","first-page":"109063","DOI":"10.1016\/j.diabres.2021.109063","volume":"186","author":"D Ziegler","year":"2022","unstructured":"Ziegler\u00a0D, et\u00a0al. Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations. Diabetes Res Clin Pract. 2022;186:109063.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"2675_CR24","first-page":"787","volume":"39","author":"F van Nooten","year":"2017","unstructured":"van Nooten\u00a0F, Treur\u00a0M, Pantiri\u00a0K, Stoker\u00a0M, Charokopou\u00a0M. Capsaicin 8\u202f% patch versus oral neuropathic pain medications for the treatment of painful diabetic peripheral neuropathy: a\u00a0systematic literature review and network meta-analysis. ClinTher. 2017;39(4):787\u2013803.e18.","journal-title":"ClinTher"},{"issue":"16","key":"2675_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1464-5491.2004.01109.x","volume":"21","author":"D Ziegler","year":"2004","unstructured":"Ziegler\u00a0D, et\u00a0al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a\u00a0meta-analysis. Diabet Med. 2004;21(16):114\u201321.","journal-title":"Diabet Med"},{"issue":"17","key":"2675_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/456279","volume":"2012","author":"GS Mijnhout","year":"2012","unstructured":"Mijnhout\u00a0GS, et\u00a0al. Alpha Lipoic Acid for Symptomatic Peripheral Neuropathy in Patients with Diabetes: A\u00a0Meta-Analysis of Randomized Controlled Trials. Int J Endocrinol. 2012;2012(17):1\u20138.","journal-title":"Int J Endocrinol"},{"issue":"18","key":"2675_CR27","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1111\/dme.13083","volume":"33","author":"N \u00c7akici","year":"2016","unstructured":"\u00c7akici\u00a0N, et\u00a0al. Systematic review of treatments for diabetic peripheral neuropathy. Diabet Med. 2016;33(18):1466\u201376.","journal-title":"Diabet Med"},{"key":"2675_CR28","unstructured":"Dy S, et\u00a0al. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy. Rockv. 2017;19."},{"issue":"106075","key":"2675_CR29","first-page":"20","volume":"177","author":"G Cassanego","year":"2022","unstructured":"Cassanego\u00a0G, et\u00a0al. Evaluation of the analgesic effect of \u03b1\u2011lipoic acid in treating pain disorders: A\u00a0systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2022;177(106075):20.","journal-title":"Pharmacol Res"},{"key":"2675_CR30","doi-asserted-by":"crossref","unstructured":"Hsieh R\u2011Y, et\u00a0al. Effects of Oral Alpha-Lipoic Acid Treatment on Diabetic Polyneuropathy: A\u00a0Meta-Analysis and Systematic Review. Nutrients. 2023;15.","DOI":"10.3390\/nu15163634"},{"key":"2675_CR31","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.2337\/dc11-0503","volume":"34","author":"D Ziegler","year":"2011","unstructured":"Ziegler\u00a0D, et\u00a0al. Efficacy and safety of antioxidant treatment with \u03b1\u2011lipoic acid over 4\u00a0years in diabetic polyneuropathy: the NATHAN 1\u00a0trial. Diabetes Care. 2011;34:2054\u201360.","journal-title":"Diabetes Care"},{"issue":"10","key":"2675_CR32","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1055\/s-2008-1065351","volume":"116","author":"H Stracke","year":"2008","unstructured":"Stracke\u00a0H, et\u00a0al. Exp Clin Endocrinol Diabetes. 2008;116(10):600\u20135. https:\/\/doi.org\/10.1055\/s-2008-1065351.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2675_CR33","doi-asserted-by":"publisher","first-page":"155565","DOI":"10.1016\/j.metabol.2023.155565","volume":"144","author":"D Ziegler","year":"2023","unstructured":"Ziegler\u00a0D, et\u00a0al. Association between diabetes and thiamine status\u2014A systematic review and meta-analysis. Metabolism. 2023;144:155565.","journal-title":"Metabolism"},{"key":"2675_CR34","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1007\/s00125-007-0771-4","volume":"50","author":"PJ Thornalley","year":"2007","unstructured":"Thornalley\u00a0PJ, et\u00a0al. High prevalence of low plasma thiamine concentration in diabetes linked to a\u00a0marker of vascular disease. Diabetologia. 2007;50:2164\u201370.","journal-title":"Diabetologia"},{"key":"2675_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-57487-4","volume-title":"Interdisziplin\u00e4re Diagnostik \u2013 multimodaleTherapie. In: Praktische Schmerzmedizin","author":"R Baron","year":"2019","unstructured":"Baron\u00a0R, Koppert\u00a0W, Strumpf\u00a0M, Willweber-Strumpf\u00a0A. Interdisziplin\u00e4re Diagnostik \u2013 multimodaleTherapie. In: Praktische Schmerzmedizin. 4.\u00a0Aufl. Berlin, Heidelberg: Springer; 2019.","edition":"4"},{"key":"2675_CR36","first-page":"CD11976","volume":"9","author":"W Gibson","year":"2017","unstructured":"Gibson\u00a0W, Wand\u00a0BM, O\u2019Connell\u00a0NE. Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults. Cochrane Database Syst Rev. 2017;9:CD11976.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2675_CR37","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00228005015181","volume":"50","author":"C Gleiter","year":"1996","unstructured":"Gleiter\u00a0C, et\u00a0al. Influence of food intake on the bioavailability of thioctic acid entantiomers. Eur J Clin Pharmacol. 1996;50(6):513\u20134. https:\/\/doi.org\/10.1007\/s00228005015181.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"2675_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/1056-8727(92)90049-Q","volume":"6","author":"D Ziegler","year":"1992","unstructured":"Ziegler\u00a0D, Gries\u00a0FA, Sp\u00fcler\u00a0M, Lessmann\u00a0F. The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J\u00a0Diabetescomplications. 1992;6(1):49\u201357.","journal-title":"J Diabetescomplications"},{"issue":"24","key":"2675_CR39","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"A Patel","year":"2008","unstructured":"ADVANCE Collaborative Group, Patel\u00a0A, MacMahon\u00a0S, Chalmers\u00a0J, Neal\u00a0B, Billot\u00a0L, et\u00a0al. Intensive blood glucose control and vascular outcomes in patients with type\u00a02 diabetes. NEngl Jmed. 2008;358(24):2560\u201372.","journal-title":"NEngl Jmed."},{"issue":"2","key":"2675_CR40","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1001\/jama.293.2.217","volume":"293","author":"N Singh","year":"2005","unstructured":"Singh\u00a0N, Armstrong\u00a0DG, Lipsky\u00a0BA. Preventing footulcersin patientswithdiabetes. JAMA. 2005;293(2):217\u201328.","journal-title":"JAMA"},{"issue":"9","key":"2675_CR41","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans\u00a0V, Ricco\u00a0JB, Bartelink\u00a0MLEL, Bj\u00f6rck\u00a0M, Brodmann\u00a0M, Cohnert\u00a0T, et\u00a0al. 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart\u00a0J. 2018;39(9):763\u2013816.","journal-title":"Eur Heart J"},{"issue":"3","key":"2675_CR42","doi-asserted-by":"publisher","first-page":"e3657","DOI":"10.1002\/dmrr.3657","volume":"40","author":"NC Schaper","year":"2024","unstructured":"Schaper\u00a0NC, van Netten\u00a0JJ, Apelqvist\u00a0J, Bus\u00a0SA, Fitridge\u00a0R, Game\u00a0F, Monteiro-Soares\u00a0M, Senneville\u00a0E, IWGDF Editorial Board. Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update). Diabetes Metab Res Rev. 2024;40(3):e3657. https:\/\/doi.org\/10.1002\/dmrr.3657.","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"2675_CR43","doi-asserted-by":"publisher","first-page":"e3644","DOI":"10.1002\/dmrr.3644","volume":"40","author":"P Chen","year":"2024","unstructured":"Chen\u00a0P, Vilorio\u00a0NC, Dhatariya\u00a0K, Jeffcoate\u00a0W, Lobmann\u00a0R, McIntosh\u00a0C, Piaggesi\u00a0A, Steinberg\u00a0J, Vas\u00a0P, Viswanathan\u00a0V, Wu\u00a0S, Game\u00a0F. Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update). Diabetes Metab Res Rev. 2024;40(3):e3644. https:\/\/doi.org\/10.1002\/dmrr.3644.","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"2675_CR44","doi-asserted-by":"publisher","first-page":"e3687","DOI":"10.1002\/dmrr.3687","volume":"40","author":"\u00c9 Senneville","year":"2024","unstructured":"Senneville \u00c9, Albalawi\u00a0Z, van Asten\u00a0SA, Abbas\u00a0ZG, Allison\u00a0G, Arag\u00f3n-S\u00e1nchez\u00a0J, Embil\u00a0JM, Lavery\u00a0LA, Alhasan\u00a0M, Oz\u00a0O, U\u00e7kay\u00a0I, Urban\u010di\u010d-Rovan\u00a0V, Xu\u00a0ZR, Peters\u00a0EJG. IWGDF\/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF\/IDSA 2023). Diabetes Metab Res Rev. 2024;40(3):e3687. https:\/\/doi.org\/10.1002\/dmrr.3687.","journal-title":"Diabetes Metab Res Rev"},{"key":"2675_CR45","doi-asserted-by":"crossref","unstructured":"Dumville JC, Lipsky BA, Hoey C, Cruciani M, Fiscon M, Xia J. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database Syst Rev.2017(6):CD11038.","DOI":"10.1002\/14651858.CD011038.pub2"},{"issue":"3","key":"2675_CR46","first-page":"186","volume":"6","author":"M Edmonds","year":"2018","unstructured":"Edmonds\u00a0M, L\u00e1zaro-Mart\u00ednez\u00a0JL, Alfayate-Garc\u00eda\u00a0JM, Martini\u00a0J, Petit\u00a0JM, Rayman\u00a0G, et\u00a0al. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial. Lancet Diabetesendocrinol. 2018;6(3):186\u201396.","journal-title":"Lancet Diabetesendocrinol"},{"issue":"4","key":"2675_CR47","first-page":"737","volume":"24","author":"TBK Santema","year":"2016","unstructured":"Santema\u00a0TBK, Poyck\u00a0PPC, Ubbink\u00a0DT. Systematic review and meta-analysis of skin substitutes in the treatment of diabetic foot ulcers: Highlights of a\u00a0Cochrane systematic review. WoundRepairRegen. 2016;24(4):737\u201344.","journal-title":"WoundRepairRegen"},{"key":"2675_CR48","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.avsg.2018.10.013","volume":"56","author":"LH Hitchman","year":"2019","unstructured":"Hitchman\u00a0LH, Totty\u00a0JP, Raza\u00a0A, Cai\u00a0P, Smith\u00a0GE, Carradice\u00a0D, et\u00a0al. Extracorporeal shockwave therapy for diabetic foot ulcers: a\u00a0systematic review and meta-analysis. Ann Vasc Surg. 2019;56:330\u20139.","journal-title":"Ann Vasc Surg"},{"issue":"3","key":"2675_CR49","doi-asserted-by":"publisher","first-page":"e3646","DOI":"10.1002\/dmrr.3646","volume":"40","author":"DK Wukich","year":"2024","unstructured":"Wukich\u00a0DK, Schaper\u00a0NC, Gooday\u00a0C, Bal\u00a0A, Bem\u00a0R, Chhabra\u00a0A, Hastings\u00a0M, Holmes\u00a0C, Petrova\u00a0NL, Santini\u00a0AMG, Senneville\u00a0E, Raspovic\u00a0KM. Guidelines on the diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus (IWGDF 2023). Diabetes Metab Res Rev. 2024;40(3):e3646. https:\/\/doi.org\/10.1002\/dmrr.3646.","journal-title":"Diabetes Metab Res Rev"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-025-02675-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-025-02675-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-025-02675-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:13:00Z","timestamp":1779315180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-025-02675-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":49,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2675"],"URL":"https:\/\/doi.org\/10.1007\/s00508-025-02675-8","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.\u00a0K\u00f6hler, A.\u00a0Feder, D.\u00a0Hochfellner und M.\u00a0Eichner geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}